Cardio Diagnostics Holdings reported a net margin of -28,012.46% for the quarter ended Jun 2026. These financial ratios cover 19 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||
| EBT Margin | -250,321.79% | -233,211.88% | -19,266.02% | -26,156.85% | -26,140.03% | -16,365.88% | -21,467.57% | -33,672.61% | -173,942.98% | -22,517.71% | -60,053.80% | -41,219.92% | -66,722.31% | -28,012.46% | |||||
| EBIT Margin | -250,321.79% | -148,008.17% | -14,398.71% | -29,039.51% | -26,105.27% | -16,295.55% | -21,412.87% | -33,608.20% | -173,463.83% | -22,457.51% | -59,950.86% | -41,159.55% | -66,598.40% | -27,950.50% | |||||
| EBITDA Margin | -250,321.79% | -148,008.17% | -14,398.71% | -29,039.51% | -26,105.27% | -16,295.55% | -21,412.87% | -33,608.20% | -173,463.83% | -22,457.51% | -59,950.86% | -41,159.55% | -66,598.40% | -27,950.50% | |||||
| Operating Margin | -250,321.79% | -148,008.17% | -14,398.71% | -29,039.51% | -26,105.27% | -16,295.55% | -21,412.87% | -33,608.20% | -173,463.83% | -22,457.51% | -59,950.86% | -41,159.55% | -66,598.40% | -27,950.50% | |||||
| Net Margin | -250,321.79% | -233,211.88% | -19,266.02% | -26,156.85% | -26,140.03% | -16,365.88% | -21,467.57% | -33,672.61% | -173,942.98% | -22,517.71% | -60,053.80% | -41,219.92% | -66,722.31% | -28,012.46% | |||||
| FCF Margin | -348,309.37% | -60,048.75% | -10,540.28% | -41,859.32% | -7,866.87% | -17,513.29% | -17,942.33% | -30,938.23% | -149,562.55% | -21,273.06% | -54,509.70% | -38,307.99% | -58,357.16% | -25,044.10% | |||||
| Efficiency | |||||||||||||||||||
| Assets AverageAssets Avg. | 33.37M | 65.42M | 65.50M | 36.03M | 7.40M | 7.65M | 6.36M | 5.21M | 4.39M | 4.16M | 4.24M | 7.55M | 11.45M | 11.34M | 9.59M | 8.28M | 8.66M | 8.74M | |
| Invested CapitalInvested Cap. | 1.07M | 10.01M | 4.30M | 6.93M | 4.91M | 3.47M | |||||||||||||
| Asset Utilization RatioAsset Util. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Leverage & Solvency | |||||||||||||||||||
| Interest Coverage RatioInterest Cover | -0.34 | -2.43 | -2.53 | -16.05 | -714.81 | -220.47 | -363.23 | -484.94 | -347.59 | -357.93 | -547.19 | -638.40 | -519.00 | -435.51 | |||||
| Debt Ratio | 0.01 | 0.41 | 0.30 | 0.20 | |||||||||||||||
| Times Interest Earned | -0.34 | -2.43 | -2.53 | -16.05 | -714.81 | -220.47 | -363.23 | -484.94 | -347.59 | -357.93 | -547.19 | -638.40 | -519.00 | -435.51 | |||||
| Return Ratios | |||||||||||||||||||
| Return on Sales [ROS]ROS | -250,321.79% | -633,581.58% | -148,008.17% | -14,398.71% | -29,039.51% | -26,105.27% | -16,295.55% | -21,412.87% | -33,608.20% | -173,463.83% | -22,457.51% | -59,950.86% | -41,159.55% | -66,598.40% | -27,950.50% | ||||
| Return on Capital Employed [ROCE]ROCE | -1.13% | -1.78% | -3.56% | -13.33% | -237.25% | -165.67% | -261.43% | -222.57% | -213.50% | -120.95% | -53.52% | -56.83% | -71.10% | -84.51% | -81.24% | -77.03% | |||
| Return on Assets [ROA]ROA | -1.31% | -1.95% | -3.71% | -12.94% | -73.02% | -112.15% | -147.26% | -160.70% | -261.84% | -210.78% | -194.69% | -111.06% | -51.14% | -55.12% | -68.30% | -78.50% | -76.78% | -74.00% |